Does clopidogrel improve the long-term outcome after coronary artery bypass surgery?

Scandinavian Cardiovascular Journal

Volumn 39, Issue 3, 2005, Pages 135-136

  Biancari, Fausto ^a   Juvonen, Tatu ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; PLACEBO;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY OBSTRUCTION; COST BENEFIT ANALYSIS; EDITORIAL; HUMAN; ISCHEMIC HEART DISEASE; LONG TERM CARE; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT DISEASE; SURGICAL RISK; VEIN GRAFT;

CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; CORONARY STENOSIS; HUMANS; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 27844438752     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.1080/14017430510009096     Document Type: Editorial

References (13)

1. Gavaghan TP, Gebski V, Baron DW. Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study. Circulation. 1991;83:1526-33.
2. Goldman S, Copeland J, Moritz T, Henderson W, Zadino K, Ovitt T, Doherty J, Read R, Chesler E, Sako Y, et al. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelets therapy. Results of a Veterans Administration Cooperative Study. Circulation. 1989;80:1190-7.
3. Chesebro JH, Fuster V, Elveback LR, Clements IP, Smith HC, Holmes BR Jr., Bardsli WT, Pluth JR, Wallace RB, Puga FJ, et al. Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. N Engl J Med. 1984;310:209-14.
4. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71-86.
5. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet. 1996;348:1329-39.
6. Ringleb PA, Bhatt DL, Hirsh AT, Topol EJ, Hacke W. for the CAPRIE Investigators. Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events. Stroke. 2004;35:528-32.
7. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. and the Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494-502.
8. Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, Wilner C, Topol EJ. CREDO Investigators. Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial. JAMA. 2003;289:987.
9. Mehta SR, Yusuf S, Peters RJG, Bertrand ME, Lewis BS, Natarajan MK, Malmberg K, Rupprecht HJ, Zhao F. Chrolavicius S, et al. for the Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study. Lancet. 2001;358:527-33.
10. Saw J, Topol EJ. Steinhubl SR, Brennan D, Berger PB, Moliterno DJ, CREDO Investigators. Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after second or repeat intervention. Am J Cardiol. 2004;94:623-5.
11. Bhatt DL, Chew DP, Hirsch AT, Ringleb PA, Hacke W, Topol EJ. Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery. Circulation. 2001; 103: 363-8.
12. Fox KA, Mehta SR, Peters R, Zhao F, Lakkis N, Gersh BJ, Yusuf S. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: The Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation. 2004;110:1202-8.
13. Marshall T. Coronary heart disease prevention: Insights from modelling incremental cost effectiveness. BMJ. 2003;327: 1264-8.